- AstraZeneca buys MedImmune for $15.6bn
- Schering-Plough buys Organon for €11bn in cash
- Novartis buys 25% of Alcon; exercises option for 52% more
- Novartis pays $2.8bn for 20% of Roche's voting shares
- Novartis sells its Medical Nutrition unit for $2.53bn
- Novartis licenses Genentech's AMD candidate Lucentis
- Chiron refuses $4.5bn Novartis offer, later accepts $5.1bn
- Novartis acquires Hexal, Eon Labs for €5.65bn
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.